happy holding here.
will look to increase my position if it dips to low 40s to re test the low as i suspect it might given the headline downgrade.
the announcement that they will no longer be running at a loss despite the rapid expansion by 2018 is an exciting announcement. if they can avoid further CRs which seems likely given strong cash position and no debt, they will be well leveraged for eps growth in 1-2 years.
if they continue to enter new markets and ramp up the number of sellers and marketing, they should be able to grow sales >50% pa for the next 3-5 years.
- Forums
- ASX - By Stock
- YOW
- Ann: March 2017 Quarterly Report and Appendix 4C
YOW
yowie group ltd
Add to My Watchlist
0.00%
!
1.4¢

Ann: March 2017 Quarterly Report and Appendix 4C, page-44
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.211M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
YOW (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online